Journal: Redox Report : Communications in Free Radical Research
Article Title: Ivacaftor attenuates gentamicin-induced ototoxicity through the CFTR-Nrf2-HO1/NQO1 pathway
doi: 10.1080/13510002.2024.2332038
Figure Lengend Snippet: A schematic illustration of potential CFTR-Nrf2-HO1/NQO1 pathways that might mitigate gentamicin-induced hearing loss. Gentamicin causes accumulation of ROS in cochlear hair cells, resulting in oxidative stress imbalance and ultimately hair cell death. Ivacaftor plays an antioxidant role by activating the CFTR-Nrf2-HO1/NQO1 axis to protect sensory hair cells.
Article Snippet: The primary antibodies used for western blot were as follows: mouse monoclonal anti-CFTR (66928-1-Ig, Proteintech, CN), Rabbit polyclonal anti-Nrf2 (16396-1-AP, Proteintech, CN), rabbit polyclonal anti-HO1 (ab52947, Abcam, USA), NQO1 (ab80588, Abcam, USA), SOD2 (66474-1-Ig, Proteintech, CN), and Keap1 (10503-2-AP, Proteintech, CN), anti-Cleaved Caspase 3 (25128-1-AP, Proteintech, CN), anti-beta actin (66009-1-Ig, Proteintech, CN), anti-Laminb1 (66095-1-Ig, Proteintech, CN), anti-GAPDH (10494-1-AP, Proteintech, CN).
Techniques: